These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 437082)

  • 21. [Change in the weight of certain lymphoid organs as a criterion of the toxic action of antitumor preparations].
    Maliugina LL; Pol'kina RI
    Vopr Onkol; 1974; 20(3):62-9. PubMed ID: 4439803
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of enzymes on malignant tumors].
    Oleĭnik II
    Vopr Onkol; 1966; 12(11):104-9. PubMed ID: 4886755
    [No Abstract]   [Full Text] [Related]  

  • 23. [On the effect of heparin on tumor growth under experimental conditions].
    Shats VIa
    Vopr Onkol; 1966; 12(8):113-8. PubMed ID: 4880208
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacology of 1,6-Dibromo-1,6-dideoxy-dulcitol and its Cytostatic effect on transplantable tumours.
    Kellner B; Németh L; Sugár J; Gáti E; Pályi I; Döbrössy L
    Arzneimittelforschung; 1967 Aug; 17(8):1037-43. PubMed ID: 5244384
    [No Abstract]   [Full Text] [Related]  

  • 25. [Metabolic study of sarcoma 45 and Walker carcinosarcoma cells during the process of growth and exposure to anticoagulants (an enzyme cytochemical analysis)].
    Kolomina SM; Pogodina LS; Chentsov IuS; Kudriashov BA; Vasil'eva TN
    Tsitol Genet; 1982; 16(6):18-24. PubMed ID: 7157464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrastructural changes induced in Walker carcinosarcoma by treatment with dihematoporphyrin ester and light in animals with diabetes mellitus.
    Dima VF; Ionescu MD
    Roum Arch Microbiol Immunol; 2000; 59(1-2):119-30. PubMed ID: 11845470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential distribution of antitumor agents in primary and secondary tumors.
    Donelli MG; Colombo T; Broggini M; Garattini S
    Cancer Treat Rep; 1977 Oct; 61(7):1319-24. PubMed ID: 589598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Kinetic study of the effectiveness of chemotherapy of experimental metastases (using a computer)].
    Emanuél NM; Kiseleva EG; Sushchenko VV; D'iachkovskaia RF; Volkova LM
    Vopr Onkol; 1977; 23(8):64-8. PubMed ID: 198956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potentials for the use of heparin in combination with radiation therapy, Experience with ascitic Walker 256 carcinosarcoma in weanling rats.
    Torpie RJ
    J Med; 1974; 5(1):133-48. PubMed ID: 4524856
    [No Abstract]   [Full Text] [Related]  

  • 30. [Toxicity and antineoplastic activity of a new thio-TEPA analog].
    Konovalova NP; D'iachkovskaia RF; Kiseleva EG
    Vopr Onkol; 1973; 19(1):58-63. PubMed ID: 4349733
    [No Abstract]   [Full Text] [Related]  

  • 31. In vivo inhibition of tumor growth by cyclic adenosine 3',5'-monophosphate derivatives.
    Cho-Chung YS
    Cancer Res; 1974 Dec; 34(12):3492-6. PubMed ID: 4371966
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antitumor activity and toxicity of combined doxorubicin and disodium salt of methylene-1,1-diphosphonic acid].
    Stukov AN; Mironiuk TN; Kon'kov SA; Krylova IM; Reztsova VV; Filov VA; Ivin BA
    Vopr Onkol; 1998; 44(1):100-2. PubMed ID: 9578741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of sodium citrate on the growth of transplantable tumors].
    Prizhivoĭt GN
    Vopr Onkol; 1969; 15(3):77-83. PubMed ID: 5002347
    [No Abstract]   [Full Text] [Related]  

  • 34. Antitumor effects of methylglyoxal-bis(N-4-methylthiosemicarbazone) and their potentiation in pyridoxine-deficient animals.
    Mihich E; Nichol CA
    Cancer Res; 1965 Jul; 25(6):794-801. PubMed ID: 5214034
    [No Abstract]   [Full Text] [Related]  

  • 35. [Time factor in evaluating antineoplastic agents].
    Syrkin AB
    Farmakol Toksikol; 1972; 35(1):75-9. PubMed ID: 5011523
    [No Abstract]   [Full Text] [Related]  

  • 36. [Fibrinolysis in the blood of animals exposed to the chronic per os use of a heparin-urea complex].
    Kudriashov BA; Liapina LA
    Farmakol Toksikol; 1977; 40(5):559-63. PubMed ID: 923778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of heparin on the growth of Walker carcinoma].
    Wieser O; Emminger A; Mohr U
    Krebsarzt; 1968; 23(3):195-6. PubMed ID: 4174573
    [No Abstract]   [Full Text] [Related]  

  • 38. Biological activity of bacterial lectins and their molecular complexes with heterocyclic bis-adducts.
    Welchinskaya HV; Piecuszak B; Kovalenko EA; Sharykina NI; Getman KI; Podgorsky VS
    Mikrobiol Z; 2003; 65(5):20-5. PubMed ID: 14723158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of heparin and defibrase on transplantability of syngeneic tumors in mice.
    Klener P; Bubeník J; Donner L
    Neoplasma; 1978; 25(5):631-5. PubMed ID: 740064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of heparin on the metastasis of inoculated tumor in rats].
    Yamaguchi S
    Med J Osaka Univ; 1972 Sep; 23(1):31-9. PubMed ID: 4265202
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.